Embecta seeks high growth with low tech

Until last week Becton Dickinson was the world’s biggest provider of insulin syringes and pen injectors. On Friday it spun out Embecta, which now assumes that mantle. Embecta has ambitions to grow its injector business, but also to diversify away from its low-tech core, and is willing to spend lavishly to do so.